| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ff5a28ea093b9f57422ae28693f59ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad061f7ebc923ca7fdd83fd68910b795 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2021-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4f9422a2a8636e276cc5cf1c922cc07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b5ea278c8da256d75f90e17ac1a9448 |
| publicationDate |
2022-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022047530-A1 |
| titleOfInvention |
Use of hordenine in preparing drug for treating hypophysoma |
| abstract |
The present disclosure discloses the use of hordenine in the preparation of drugs for treating pituitary tumors, and relates to the technical field of biopharmaceuticals. Specifically, in this use, the inventor has found that hordenine can help treat prolactinoma and adrenocorticotrophic hormone adenoma and exert drug efficacy by inhibiting a TLR4/NF-κB/MAPK signaling pathway, solving the dilemma of medication shortage for patients of prolactinoma and adrenocorticotrophic hormone adenoma. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114404593-A |
| priorityDate |
2019-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |